Pål Rasmus Njølstad
@njolstad.bsky.social
Visiting Prof, Novo Nordisk Foundation Center for Basic Metabolic Disease, Univ Copenhagen; Head & Prof, Dep Clinical Science & Mohn Center for Diabetes Precision Medicine, Univ of Bergen, Norway
So far, the heterogeneity of diabetes has primarily been studied in adults. In the Norwegian Childhood Diabetes Registry we found that the structure of pediatric diabetes is more complex than the usual classification.
doi.org/10.1101/2025...
doi.org/10.1101/2025...
Heterogeneity in paediatric diabetes clinical presentation and its link to disease severity
Background Diabetes subtypes with different clinical profiles have been found and replicated in adults. However, clinical heterogeneity of paediatric-onset diabetes remains unexplored. Better capture ...
doi.org
November 24, 2025 at 8:07 AM
So far, the heterogeneity of diabetes has primarily been studied in adults. In the Norwegian Childhood Diabetes Registry we found that the structure of pediatric diabetes is more complex than the usual classification.
doi.org/10.1101/2025...
doi.org/10.1101/2025...
Now: PhD defence Haydee Alvarez on CNVs in Addison‘s disease and diabetes. AHH Auditorium 12.15
September 9, 2025 at 10:22 AM
Now: PhD defence Haydee Alvarez on CNVs in Addison‘s disease and diabetes. AHH Auditorium 12.15
Haydee Alvarez PhD trial lecture today: Genomic prediction and precision medicine in diabetes😀
September 9, 2025 at 8:33 AM
Haydee Alvarez PhD trial lecture today: Genomic prediction and precision medicine in diabetes😀
Annual meeting Norw Childhood Diabetes Registry: Speaker Dr Carmel Smart at John Hunter Hosp, Univ of Newcastle, Au: excellent average HbA1c 59 mmol/mol might be due to consistent message from health care workers on food and insulin treatment
May 26, 2025 at 8:22 AM
Annual meeting Norw Childhood Diabetes Registry: Speaker Dr Carmel Smart at John Hunter Hosp, Univ of Newcastle, Au: excellent average HbA1c 59 mmol/mol might be due to consistent message from health care workers on food and insulin treatment
Opening annual meeting Norwegian Childhood Diabetes Registry st Oslo. Leader Prof Torild Skrivarhaug welcomes 70 participants
May 26, 2025 at 8:02 AM
Opening annual meeting Norwegian Childhood Diabetes Registry st Oslo. Leader Prof Torild Skrivarhaug welcomes 70 participants
Reposted by Pål Rasmus Njølstad
This Medical News article discusses how the popularity of the antiobesity drugs #semaglutide and #tirzepatide may affect uptake of bariatric surgery.
#MedSky
#MedSky
Weight-Loss Drugs Are Reshaping the Future of Bariatric Surgery
This Medical News article discusses how the popularity of the antiobesity drugs semaglutide and tirzepatide may affect uptake of bariatric surgery.
jamanetwork.com
January 31, 2025 at 4:45 PM
This Medical News article discusses how the popularity of the antiobesity drugs #semaglutide and #tirzepatide may affect uptake of bariatric surgery.
#MedSky
#MedSky
Reposted by Pål Rasmus Njølstad
Pre-print alert!! Did you know that exploration of loss and gain of eQTL regulation in normal versus disease condition from scRNAseq can reveal pos-transcriptional regulatory mechanisms (e.g. miRNA)? Have a look at our work, led by awesome @tdwinter.bsky.social, in which we focus on human islets.
January 27, 2025 at 8:28 AM
Pre-print alert!! Did you know that exploration of loss and gain of eQTL regulation in normal versus disease condition from scRNAseq can reveal pos-transcriptional regulatory mechanisms (e.g. miRNA)? Have a look at our work, led by awesome @tdwinter.bsky.social, in which we focus on human islets.
Reposted by Pål Rasmus Njølstad
Today, we published our ☀️2024 Annual Report!🌕
To learn more about our achievements and our renewed commitment to work in community to shape a more equitable, open, and transparent scholarly evaluation landscape, check out our full report here: zenodo.org/records/1467....
#PREreview #annualreport
To learn more about our achievements and our renewed commitment to work in community to shape a more equitable, open, and transparent scholarly evaluation landscape, check out our full report here: zenodo.org/records/1467....
#PREreview #annualreport
2024: A Year of Expansion and Introspection
Today we published our 2024 Annual Report, sharing our achievements from last year and renewing our commitment to work in collaboration with you to shape an equitable, open, and transparent scholarly ...
content.prereview.org
January 16, 2025 at 8:49 PM
Today, we published our ☀️2024 Annual Report!🌕
To learn more about our achievements and our renewed commitment to work in community to shape a more equitable, open, and transparent scholarly evaluation landscape, check out our full report here: zenodo.org/records/1467....
#PREreview #annualreport
To learn more about our achievements and our renewed commitment to work in community to shape a more equitable, open, and transparent scholarly evaluation landscape, check out our full report here: zenodo.org/records/1467....
#PREreview #annualreport
Reposted by Pål Rasmus Njølstad
How are multiplexed assays of variant effect (MAVEs) transforming genetic variant curation?
Dr. Douglas Fowler of IGVF joins the DNA Today podcast to discuss how MAVEs improve variant interpretation and are advancing precision medicine.
🎧 Listen now: dnatodaypodcast.podbean.com/e/325-revolu...
Dr. Douglas Fowler of IGVF joins the DNA Today podcast to discuss how MAVEs improve variant interpretation and are advancing precision medicine.
🎧 Listen now: dnatodaypodcast.podbean.com/e/325-revolu...
#325 Revolutionizing Variant Curation with MAVEs | DNA Today: A Genetics Podcast
We explore cutting-edge technologies transforming genetic variant curation: multiplexed assays of variant effect (MAVEs).
Joining us are two leading experts in the field:
Dr. Lea Starita, Associate ...
dnatodaypodcast.podbean.com
January 30, 2025 at 5:07 PM
How are multiplexed assays of variant effect (MAVEs) transforming genetic variant curation?
Dr. Douglas Fowler of IGVF joins the DNA Today podcast to discuss how MAVEs improve variant interpretation and are advancing precision medicine.
🎧 Listen now: dnatodaypodcast.podbean.com/e/325-revolu...
Dr. Douglas Fowler of IGVF joins the DNA Today podcast to discuss how MAVEs improve variant interpretation and are advancing precision medicine.
🎧 Listen now: dnatodaypodcast.podbean.com/e/325-revolu...
5th Retreat Mohn Center for Diabetes Precision Medicine: Marc Vaudel explains the background and plans for his ERC CoG on genetics and proteomics of pregnancy symptoms and consequences @trondmohnfoundation @medofak_uib @haukeland_no
January 16, 2025 at 3:48 PM
5th Retreat Mohn Center for Diabetes Precision Medicine: Marc Vaudel explains the background and plans for his ERC CoG on genetics and proteomics of pregnancy symptoms and consequences @trondmohnfoundation @medofak_uib @haukeland_no
5th Retreat Mohn Center for Precision Diabetes Medicine: Let’s Talk Science Session lead my ESRs. Here, Lucas Unger on method repertoire for islet cells focused on cell fate @TrondMohnResearchFoundation @haukeland_no @medfak_uib
January 16, 2025 at 2:23 PM
5th Retreat Mohn Center for Precision Diabetes Medicine: Let’s Talk Science Session lead my ESRs. Here, Lucas Unger on method repertoire for islet cells focused on cell fate @TrondMohnResearchFoundation @haukeland_no @medfak_uib
5th Retreat Mohn Center for Diabetes Precision Medicine at Hotel Terminus. Here, Andrea Magugliani discusses social media and our role and obligation to engage. @haukeland_no @medfakuib @mohnfoundation
January 16, 2025 at 1:28 PM
5th Retreat Mohn Center for Diabetes Precision Medicine at Hotel Terminus. Here, Andrea Magugliani discusses social media and our role and obligation to engage. @haukeland_no @medfakuib @mohnfoundation
Reposted by Pål Rasmus Njølstad
True luxury is found in the simplest moments.
December 18, 2024 at 8:59 PM
True luxury is found in the simplest moments.
Reposted by Pål Rasmus Njølstad
Some folks are pretty good seeing things coming.
December 18, 2024 at 11:37 AM
Some folks are pretty good seeing things coming.
Reposted by Pål Rasmus Njølstad
One proteome to rule them all? We have published a tool to create custom protein databases from large panels of genotypes in @naturemethods.bsky.social. Check the post below to see why it matters, why you should use it, and how it will make your life both easier and more difficult.
ProHap: A New Tool for Capturing Genetic Diversity in Proteomics
communities.springernature.com
December 10, 2024 at 3:41 AM
One proteome to rule them all? We have published a tool to create custom protein databases from large panels of genotypes in @naturemethods.bsky.social. Check the post below to see why it matters, why you should use it, and how it will make your life both easier and more difficult.
Reposted by Pål Rasmus Njølstad
Diabetes mellitus—Progress and opportunities in the evolving epidemic. Reposting our landmark recent review in @cellpress.bsky.social . 11 citations in 4 months! www.sciencedirect.com/science/arti...
Diabetes mellitus—Progress and opportunities in the evolving epidemic
Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads to complications that reduce quality of life and increase mor…
www.sciencedirect.com
November 29, 2024 at 4:25 PM
Diabetes mellitus—Progress and opportunities in the evolving epidemic. Reposting our landmark recent review in @cellpress.bsky.social . 11 citations in 4 months! www.sciencedirect.com/science/arti...
Happy to be part of super proteomics group reporting in Nature Methods today - ProHap: A tool to distinguish protein haplotypes - unique opportunity increasing knowledge at genomics - proteomics www.nature.com/articles/s41... @mohnfoundation.bsky.social #PRECISE_DIA @naturemethods.bsky.social
www.nature.com
December 9, 2024 at 6:21 PM
Happy to be part of super proteomics group reporting in Nature Methods today - ProHap: A tool to distinguish protein haplotypes - unique opportunity increasing knowledge at genomics - proteomics www.nature.com/articles/s41... @mohnfoundation.bsky.social #PRECISE_DIA @naturemethods.bsky.social
Hello😃 New to this platform - just left X as Twitter is gone and most likely won’t come back. Seems to be many good friends here, too☺️
December 9, 2024 at 5:16 PM
Hello😃 New to this platform - just left X as Twitter is gone and most likely won’t come back. Seems to be many good friends here, too☺️